Technology
The Delaware-based company provides self-insured employers with data and strategies to reduce costs associated with prescription medications.
The company's stock price dropped after it released its first-quarter earnings and lowered its full-year guidance despite an increase in revenue.
The company's new offerings will allow users to determine their cardiovascular age and overall cardiovascular health.
The companies will utilize Flatiron Clinical Pipe to connect electronic health records to electronic data capture for clinical trial data gathering.
Med-Gemini-3D can read 3D scans, generate radiology reports and answer questions, while Med-Gemini-Polygenic can predict health outcomes based on genomic data.
Payments and revenue cycle-management company Sift Healthcare, nursing-scheduling and management platform In-House Health, and analytics and risk-stratification company OptMyCare also secured funding.
It will validate BrainEye's 60-second eye movement test to about 500 participants.
Clover Health reports first-time profitability on an adjusted EBITDA basis in the first quarter.
The company notified the SEC of a data breach after discovering an unauthorized party stole consumers' sensitive information, including patient health data.
It confidently relies on expert knowledge based on two decades of research with young people.